U.S. To Fund HPV Vaccination Campaign In Micronesia Region
Main Category: Cervical Cancer / HPV VaccineArticle Date: 09 Jan 2009 - 3:00 PDT
| Patient / Public: | ![]() |
1 (1 votes) |
| Healthcare Prof: | ![]() |
2.75 (4 votes) |
The U.S. next month will launch a human papillomavirus vaccination campaign aimed at preventing cervical cancer in the Pacific island nations of the Federated States of Micronesia, the Marshall Islands and Palau, Jean-Paul Chaine, regional epidemiologist at the Centers for Disease Control and Prevention, said on Wednesday, Agence France-Presse reports. The program, which will cost $9 million, will fund HPV vaccinations for more than 30,000 girls ages 10 to 18. Although officials intended to launch the program in early 2008, implementation was delayed by funding obstacles, Chaine said. Some of the island states could launch the vaccine campaign as early as next month, he added.
Cervical cancer was the second most prevalent cancer in the Marshall Islands in 2007 and is estimated to affect women at a rate six times greater than in the U.S., Chaine said. The HPV vaccine protects against the types of HPV that cause most cases of cervical cancer and genital warts. According to Agence France-Presse, the three countries targeted for the program have "compacts of free association" with the U.S., which allows them to qualify for many U.S.-funded health and education programs (Agence France-Presse, 1/7).
Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.
© 2008 The Advisory Board Company. All rights reserved.
Visit our cervical cancer / hpv vaccine section for the latest news on this subject.
MLA
12 Feb. 2012. <http://www.medicalnewstoday.com/releases/134875.php>
APA
http://www.medicalnewstoday.com/releases/134875.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




